News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioMarin Pharmaceutical Inc. (BMRN) Buys Zacharon Pharmaceuticals, Inc. for $10 Million



1/8/2013 8:15:36 AM

BioMarin Pharmaceutical Inc. bought Zacharon Pharmaceuticals of San Diego for $10 million. Novato-based BioMarin (NASDAQ: BMRN) may pay more in the deal, depending on whether Zacharon hits certain milestones. Zacharon is working on treatments aimed at mucopolysaccharidosis disorders and also diseases like Tay Sachs and Sandhoff.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES